Urban Gro (UGRO) $8.00 Conference Call 8:30 This Morning.
urban-gro, Inc. to Report Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call
– Company to host conference call and audio webcast on...
2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its Vision
LIVE CHART
https://youtu.be/X_DRzL6MAOU
Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.
Transcript follows.
Hapbee CEO Live with the Wall Street Reporter
Listen in as Hapbee CEO Scott Donnell chats with the Wall Street Reporter about all things...
Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech Six Pack' list. The first addition...
EMulate Therapeutics to Participate in the Venture Summit – Virtual Connect West on March...
SEATTLE, WA / ACCESSWIRE / March 11, 2021 / EMulate Therapeutics Inc, a clinical-stage therapeutic device company, announced today that management will participate in the...
Wall Street Pounces on Hydroponics.
Indoor Growing & Hydroponics Outperform Both the Market and Marijuana Sector.
Investor attention is focusing on the Hydroponic sector and for good reason.
In June...
Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.
Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today.
We're beginning to believe (and it may be a "brief-belief") that during...
Video: Mel Gibson Stem Cell Testimonial.
Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert.
Joe Rogan interviews Stem Cell Institute founder Neil...
Mitesco (MITI) $0.45 to Open its First Medical Clinic.
LIVE QUOTE
By George, they did it.
Many companies public or private fall short of their ambitious plans. They either kick the can, modify plans...
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
The 2021 Biotech Six Pack, Six Stocks We Expect to Double.
We're still putting the 2021 list together now, but rather than waiting to announce...












